{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:13:54Z","timestamp":1790165634608,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clnu.2024.05.046","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:28:37Z","timestamp":1717140517000},"page":"1800-1808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-7806","authenticated-orcid":false,"given":"Laura","family":"Orioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Samaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiswendsida","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"de Barsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Lause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Deswysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Navez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Thissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Loumaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13054-022-04253-0","article-title":"The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis","volume":"27","author":"Fazzini","year":"2023","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.clnu.2024.05.046_bib3","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.biocel.2013.06.016","article-title":"Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses","volume":"45","author":"Baracos","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Writing group for the European working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.046_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.046_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jamda.2012.10.009","article-title":"Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review","volume":"14","author":"Mijnarends","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.clnu.2024.05.046_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcsm.12268","article-title":"Pitfalls in the measurement of muscle mass: a need for a reference standard","volume":"9","author":"Buckinx","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clnu.2024.05.046_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/jappl.2000.89.2.465","article-title":"Estimation of skeletal muscle mass by bioelectrical impedance analysis","volume":"89","author":"Janssen","year":"2000","journal-title":"J\u00a0Appl Physiol"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.046_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clnu.2014.07.010","article-title":"Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults","volume":"34","author":"Sergi","year":"2015","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib10","doi-asserted-by":"crossref","first-page":"G543","DOI":"10.1152\/ajpgi.00184.2021","article-title":"Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia","volume":"321","author":"Alexopoulos","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clnu.2024.05.046_bib11","article-title":"Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients","volume":"42","author":"Nishikawa","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.046_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000496469","article-title":"Myostatin as a biomarker for diagnosis or prognosis of frailty and sarcopenia: current knowledge","volume":"65","author":"Arrieta","year":"2019","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib13","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1038\/s41598-021-87974-6","article-title":"Prediction of sarcopenia using a battery of circulating biomarkers","volume":"11","author":"Qaisar","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.046_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148372","article-title":"Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction","volume":"131","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"25","key":"10.1016\/j.clnu.2024.05.046_bib15","doi-asserted-by":"crossref","first-page":"14938","DOI":"10.1073\/pnas.95.25.14938","article-title":"Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting","volume":"95","author":"Gonzalez-Cadavid","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib16","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.046_bib17","doi-asserted-by":"crossref","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","article-title":"Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting","volume":"300","author":"Breitbart","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.046_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080454","article-title":"Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients","volume":"8","author":"Breitbart","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.046_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/IJPC.IJPC_82_17","article-title":"Quality of life among cancer patients","volume":"23","author":"Nayak","year":"2017","journal-title":"Indian J Palliat Care"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.046_bib20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/bjc.2017.300","article-title":"Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England","volume":"117","author":"Syriopoulou","year":"2017","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1186\/s12889-021-12009-8","article-title":"The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study","volume":"21","author":"Stephenson","year":"2021","journal-title":"BMC Publ Health"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.046_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/atm.2017.03.107","article-title":"Morbidity and mortality associated with obesity","volume":"5","author":"Abdelaal","year":"2017","journal-title":"Ann Transl Med"},{"issue":"16","key":"10.1016\/j.clnu.2024.05.046_bib23","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.3390\/ijms22168491","article-title":"Cancer cachexia: its mechanism and clinical significance","volume":"22","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.046_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"17","key":"10.1016\/j.clnu.2024.05.046_bib25","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cells11172671","article-title":"Transforming growth factor-beta signaling in cancer-induced cachexia: from molecular pathways to the clinics","volume":"11","author":"Balsano","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clnu.2024.05.046_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.615849","article-title":"Anabolic resistance of muscle protein turnover comes in various shapes and sizes","volume":"8","author":"Paulussen","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnu.2024.05.046_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnut.2019.00087","article-title":"Obesity alters the muscle protein synthetic response to nutrition and exercise","volume":"6","author":"Beals","year":"2019","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnu.2024.05.046_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.046_bib29","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/oby.23563","article-title":"Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: a systematic review and meta-analysis","volume":"30","author":"Sarma","year":"2022","journal-title":"Obesity"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.046_bib30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/oby.22190","article-title":"Fat-Free mass and skeletal muscle mass five years after bariatric surgery","volume":"26","author":"Davidson","year":"2018","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.clnu.2024.05.046_bib31","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s11695-020-04654-6","article-title":"Rate and determinants of excessive fat-free mass loss after bariatric surgery","volume":"30","author":"Nuijten","year":"2020","journal-title":"Obes Surg"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib32","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.046_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ejendo\/lvad122","article-title":"Identification of myokines susceptible to improve glucose homeostasis after bariatric surgery","volume":"189","author":"Orioli","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245678","article-title":"Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: a cross-sectional study","volume":"16","author":"Kurose","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.046_bib36","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.046_bib37","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"issue":"5572","key":"10.1016\/j.clnu.2024.05.046_bib38","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"issue":"6628","key":"10.1016\/j.clnu.2024.05.046_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ndt\/gfz210","article-title":"Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)-a randomized controlled trial","volume":"36","author":"Zhou","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00223-016-0118-6","article-title":"Factors associated with the serum myostatin level in patients undergoing peritoneal dialysis: potential effects of skeletal muscle mass and vitamin D receptor activator use","volume":"99","author":"Yamada","year":"2016","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.046_bib42","first-page":"511","article-title":"Myostatin and insulin-like growth factor 1 are biomarkers of muscle strength, muscle mass, and mortality in patients on hemodialysis","volume":"29","author":"Delanaye","year":"2019","journal-title":"J\u00a0Ren Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.046_bib43","first-page":"541","article-title":"Reduced serum myostatin concentrations associated with genetic muscle disease progression","volume":"264","author":"Burch","year":"2017","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.046_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13420","article-title":"Identification of frailty and sarcopenia in hospitalised older people","volume":"51","author":"Echeverria","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clnu.2024.05.046_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","article-title":"Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay","volume":"5","author":"Bergen","year":"2015","journal-title":"Skeletal Muscle"},{"issue":"18","key":"10.1016\/j.clnu.2024.05.046_bib46","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.046_bib47","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/jcsm.12613","article-title":"Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity","volume":"11","author":"Baker","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.046_bib49","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2003-032047","article-title":"Changes in muscle myostatin expression in obese subjects after weight loss","volume":"89","author":"Milan","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.046_bib50","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.046_bib51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3350\/cmh.2020.0005","article-title":"The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma","volume":"26","author":"Choi","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.046_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/07853899809005854","article-title":"Preanalytical and analytical factors affecting laboratory results","volume":"30","author":"Irjala","year":"1998","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib53","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"10","key":"10.1016\/j.clnu.2024.05.046_bib54","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2012-1273","article-title":"Endocrine and clinical correlates of myostatin serum concentration in men--the STRAMBO study","volume":"97","author":"Szulc","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clnu.2024.05.046_bib55","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/nu12082401","article-title":"Myostatin as a biomarker of muscle wasting and other pathologies-state of the art and knowledge gaps","volume":"12","author":"Baczek","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.046_bib56","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin decreases with aerobic exercise and associates with insulin resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.046_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000095354","article-title":"Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression","volume":"50","author":"Larsen","year":"2006","journal-title":"Ann Nutr Metab"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.046_bib58","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/metabo12111146","article-title":"The effects of dietary supplements, nutraceutical agents, and physical exercise on myostatin levels: hope or hype?","volume":"12","author":"Santos","year":"2022","journal-title":"Metabolites"}],"updated-by":[{"DOI":"10.1016\/j.clnu.2025.03.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:18:37Z","timestamp":1743848317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424001924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0261561424001924"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.046","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}